Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: Mifepristone

  • New Research on Advance Provision Reveals Interest and Use in United States Since 2022

    Interest in advance provision of abortion medication was high even before the U.S. Supreme Court overturned Roe v. Wade, according to recent research. Many of those interested in advance provision were more likely to be highly motivated to prevent pregnancy. They had been using highly effective contraceptives, were well-educated, had private insurance, and were not poor.

  • As Uncertainty Looms, More People Request Advance Provision of Mifepristone

    Interest in advance provision of abortion medications mifepristone and misoprostol has increased dramatically in the post-Roe era. It remains popular as a U.S. Supreme Court case looms over whether mifepristone should remain available. Advance provision is one tool to help expand access to the medication.

  • Mifepristone as a Treatment Option for Adenomyosis

    This multicenter, placebo-controlled, double-blind randomized clinical trial was conducted in 10 hospitals in China and enrolled 134 patients with diagnosed adenomyosis to evaluate mifepristone as an effective treatment for adenomyosis pain symptoms. Among the intervention group, 98.1% had total remission of adenomyosis pain symptoms as well as improved secondary outcomes with no serious adverse events. Mifepristone is promising for treating pain from adenomyosis.

  • Society of Family Planning Issues Clinical Recommendation for Medication Abortion

    As maternity and OB/GYN deserts spread across the United States, medication abortion to expel the fetus and placenta from the uterus without a surgical procedure is possible and can work safely and well between 14 weeks and nearly 28 weeks of gestation. There are few absolute contraindications to medication abortion from 14 to 27 weeks of gestation, according to the Society of Family Planning and Society of Maternal-Fetal Medicine’s new clinical recommendation.

  • The Studied and Unstudied Dangers of ‘Abortion Reversal’

    Colorado’s Senate Bill 190, signed in May 2023, declared the practice of “abortion reversal” to be unprofessional conduct, meaning that healthcare providers providing this treatment could face sanctions to their licensure. However, Colorado’s Medical Board subsequently issued a draft rule declaring “abortion reversal” as “generally accepted standard of practice” and, therefore, potentially acceptable. Clearly, confusion exists among state medical boards and legislatures, and, potentially, among healthcare providers. This commentary will review both the medical evidence regarding “abortion reversal” and the legal context so that providers can be better informed and communicate the best evidence to their patients.

  • Patients Desire Telemedicine for Abortion Care

    New research confirms previous studies in demonstrating the safety and efficacy of medication abortion pills. Studies also show there is strong desire for this option among people seeking an end to their pregnancy.

  • People Can Safely Self-Manage Medication Abortion After 10 Weeks

    Abortion care for women in their late first trimester and second trimester of pregnancy has been abolished in some states — even when the patient’s health or life is at risk during a miscarriage or other pregnancy crisis. As increasing numbers of people turn to self-managed abortion for ending their pregnancies, this option has not been seen as an alternative for U.S. women who are more than 10 weeks pregnant — until now.

  • Abortion Bans End Standard Pregnancy Care in Large Swaths of the United States

    When South Carolina and North Carolina passed abortion bans in May 2023, they were among the last states in the Southeast to end standard pregnancy and abortion care. Standard abortion care for women in most of the South and parts of the Midwest will now be denied to all but a small percentage of people. Those who want or need abortion care a couple of months into pregnancy will need to travel hundreds of miles to a state where abortion care is legal.

  • Misoprostol Alone Is an Option for Self-Managed Abortion

    Self-managed medication abortion with misoprostol alone can work well when mifepristone is unavailable because of state laws or other access obstacles, according to a recent study.

  • Access to Mifepristone Still in Legal Limbo

    A federal judge may block the use of the safe and effective abortion drug mifepristone after hearing a lawsuit by an anti-abortion organization. The group claimed the FDA had improperly approved mifepristone in 2000.